Abstract
Reinvigorating the function of exhausted CD8+ T cells during chronic viral infection and cancer is a major goal of current immunotherapy regimens. Here, we discuss recent advances in our understanding of exhausted CD8+ T cell heterogeneity as well as the potential differentiation trajectories that exhausted T cells follow during chronic infection and/or cancer. We highlight surmounting evidence suggesting that some T cell clones are divergent in nature and can develop into either terminally differentiated effector or exhausted CD8+ T cells. Lastly, we consider the potential therapeutic implications of such a bifurcation model of CD8+ T cell differentiation, including the intriguing hypothesis that redirecting progenitor CD8+ T cell differentiation along an effector pathway may serve as a novel approach to mitigate T cell exhaustion.
Original language | English (US) |
---|---|
Pages (from-to) | 276-286 |
Number of pages | 11 |
Journal | Trends in Immunology |
Volume | 44 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2023 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology